Group One Trading, L.P. Clene Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.28 - $0.53 $38,782 - $73,409	138,509 Added 3567.98%	142,391 $61,000
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.55 $1,009 - $2,135	3,882 New	3,882 $1,000
Q2 2023 Aug 09, 2023	BUY	$0.78 - $1.22 $4,475 - $7,000	5,738 New	5,738 $5,000
Q4 2022 Feb 09, 2023	BUY	$0.92 - $40.2 $116,232 - $5.08 Million	126,340 New	126,340 $126,000
Q2 2022 Aug 11, 2022	BUY	$2.1 - $4.12 $210 - $412	100 Added 3.15%	3,276 $8,000
Q1 2022 May 12, 2022	SELL	$2.42 - $4.42 $20,586 - $37,600	-8,507 Reduced 72.82%	3,176 $13,000
Q4 2021 Feb 11, 2022	BUY	$3.95 - $7.53 $46,147 - $87,972	11,683 New	11,683 $48,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.